Janet Mj Hammond Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

AVIR Quotes by TradingView

Janet Mj Hammond is Chief Development Officer of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 81,388 shares of AVIR, which is worth approximately $242,536. The most recent transaction as insider was on Jan 31, 2025, when has been sold 14,134 shares (Common Stock) at a price of $3.06 per share, resulting in proceeds of $43,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.4K
130.16% 3M change
130.16% 12M change
Total Value Held $242,536

Janet MJ Hammond Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
SELL
Payment of exercise price or tax liability
$43,250 $3.06 p/Share
14,134 Reduced 14.8%
81,388 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
11,250 Added 10.54%
95,522 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
46,800 Added 35.71%
84,272 Common Stock
Feb 01 2024
SELL
Open market or private sale
$53,871 $3.84 p/Share
14,029 Reduced 28.4%
35,362 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
46,800 Added 48.65%
49,391 Common Stock
JMH

Janet Mj Hammond

Chief Development Officer
Boston, MA

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVIR